MAB564-100

antibody from R&D Systems

Targeting: VEGFA VEGF, VEGF-A, VPF

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

MAB564-100

Provider

R&D Systems

Product name

Rat VEGF164 Antibody

Antibody type

Monoclonal

Description

Protein A or G purified from hybridoma culture supernatant. Detects rat VEGF164 in direct ELISAs and Western blots. Shows 50 - 100% cross-reactivity with recombinant mouse (rm) VEGF120, rmVEGF164, recombinant human (rh) VEGF121, rhVEGF165, and rhVEGF189 and no cross-reactivity with rmVEGF115. Recognizes an epitope found between amino acids 78-120 of rmVEGF120. This segment is present in all VEGF isoforms except rmVEGF115.

Reactivity

Rat

Host

Mouse

Conjugate

Unconjugated

Antigen sequence

AAA41211.1


Isotype

IgG

Antibody clone number

123704

Vial size

100 ug

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

References

Submitted references

Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats.

Gao X, Wu D, Dou L, Zhang H, Huang L, Zeng J, Zhang Y, Yang C, Li H, Liu L, Ma B, Yuan Q
Brain research bulletin 2019 Jul;149:42-52

---

Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments.

Peng Y, Huang S, Wu Y, Cheng B, Nie X, Liu H, Ma K, Zhou J, Gao D, Feng C, Yang S, Fu X
Stem cells and development 2013 Dec 15;22(24):3236-51

---

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP
Diabetes 2007 Feb;56(2):373-9

---

Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development.

Escribano M, Molero L, López-Farré A, Abarrategui C, Carrasco C, García-Mendez A, Manzarbeitia F, Martín MJ, Vázquez M, Sánchez-Fayos P, Rico L, Porres Cubero JC
Clinical science (London, England : 1979) 2004 Jan;106(1):83-91